secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-09-24T12:30:16+00:00
Accession:  0001493152-26-044078
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics prices $1.5M private placement of units with warrants
-------------------------------------------------------------------

- 903,614 units at $1.6599/unit; each includes pre-funded warrant (exercise $0.0001) and right to common warrant (exercise $1.66, 5.5-yr) subject to stockholder approval.
- Gross proceeds ~$1.5M; net for clinical trial HCW9302, IND-enabling for HCW11-018b and HCW11-040, and general corporate purposes.
- Maxim Group LLC sole placement agent; registration statement to be filed within 15 trading days of closing, effective within 60.
- Pre-funded warrants carry 9.99% beneficial ownership cap; common warrants 4.99% cap, issuable only after Nasdaq Rule 5635(d) approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226044078/0001493152-26-044078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226044078/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-044078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer